1. Georget, M, Pisan, E. 2023. [Next Generation Sequencing (NGS) for beginners]. In Revue des maladies respiratoires, 40, 345-358. doi:10.1016/j.rmr.2023.01.026. https://pubmed.ncbi.nlm.nih.gov/36863993/
2. Labat-de-Hoz, Leticia, Rubio-Ramos, Armando, Correas, Isabel, Alonso, Miguel A. 2023. The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers. In Cancers, 15, . doi:10.3390/cancers15102801. https://pubmed.ncbi.nlm.nih.gov/37345137/
3. Lind, Guro E, Ahlquist, Terje, Kolberg, Matthias, Thiis-Evensen, Espen, Lothe, Ragnhild A. 2008. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. In Journal of translational medicine, 6, 13. doi:10.1186/1479-5876-6-13. https://pubmed.ncbi.nlm.nih.gov/18346269/
4. Cao, Wei, Zhang, Zhi-Yuan, Xu, Qin, Han, Ze-Guang, Chen, Wan-Tao. 2010. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. In Molecular cancer, 9, 296. doi:10.1186/1476-4598-9-296. https://pubmed.ncbi.nlm.nih.gov/21092172/
5. Descot, Arnaud, Rex-Haffner, Monika, Courtois, Geneviève, Treisman, Richard, Posern, Guido. 2008. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression. In Molecular and cellular biology, 28, 6171-81. doi:10.1128/MCB.00303-08. https://pubmed.ncbi.nlm.nih.gov/18710951/
6. Kurashige, Junji, Sawada, Genta, Takahashi, Yusuke, Baba, Hideo, Mimori, Koshi. . Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality. In Fukuoka igaku zasshi = Hukuoka acta medica, 104, 344-9. doi:. https://pubmed.ncbi.nlm.nih.gov/24511665/